You are in:Home/Publications/Arginine dimethylation products in pediatric patients with chronic kidney disease

Prof. Eman G. Behiry :: Publications:

Title:
Arginine dimethylation products in pediatric patients with chronic kidney disease
Authors: Enas A.A. Abdallah Akram E. El-Sadekcorrespondenceemail , Eman G. Behery , Ahmed A. Azab , Naglaa M. Kamal , Mostafa A. Salama , Waleed E. Abdulghany
Year: 2016
Keywords: Not Available
Journal: Annals of Medicine and Surgery
Volume: 9
Issue: Not Available
Pages: 22-27
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Not Available
Supplementary materials Not Available
Abstract:

Background arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD). We aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function. Patients and methods 132 pediatric patients with CKD and 120 healthy age and sex matched controls were compared regarding; serum Arg, ADMA and SDMA levels. Results In comparison to their values in control subjects, serum Arg levels were significantly lower; serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in CKD patients (p values: < 0.000; = 0.054;

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus